Navigation Links
Evidence Links Protein Damage to Neurodegenerative diseases like Parkinson's and Alzheimer's

Neurodegenerative diseases - including Parkinson's, Alzheimer's, Diffuse Lewy body disease, and Multiple System Arophy - are collectively called synucleinopathies. Most commonly they become symptomatic due to a deficiency of a specific neurotransmitter - in the case of Parkinson's it is dopamine. When the neurons that produce these chemicals die or become impaired, which occurs with oxidation, the eventual results are tremors and sometimes dementia.

New evidence links oxidative damage in a protein found in nerve cells to the development of degenerative diseases of the nervous system, such as Parkinson's and Alzheimer's disease.

The first study to provide this evidence, conducted by University of Pennsylvania researchers, was published in the November 3, 2000, issue of Science.

The researchers said, "The protein, called alpha-synuclein, is one of the building blocks of the brain lesions characteristic in patients with neurodegenerative diseases. Oxidative damage, normally occurs when the body's cells are overwhelmed by molecules that have changed because they have combined with nitrogen (nitration) or oxygen (oxidation). Both types of oxidants damage lipids, nucleic acids, proteins, and other cellular components much like oxidation causes rust damage to metal in cars and buildings. This damage has been implicated in causing neurodegenerative disorders. Alpha-synuclein itself is a target of oxidative stress, specifically nitration, within these lesions. This is the first time anybody has identified nitration on a specific protein. Studies provide conclusive evidence of oxidative damage in alpha-synuclein, and that such stress may be a primary event leading to the onset and progression of neurodegenerative synucleinopathies, particularly Parkinson's. This may pave the way for developing therapies to stop or slow the oxidative damage, and thus slow or reverse the progression of these diseases."
'"/>




Page: 1

Related medicine news :

1. Evidence supporting H.pylori eradication
2. Evidence against use of Beta blockers as first choice in the treatment of primary hypertension
3. Evidences that Better Health Care Facility is Offered By Public Hospitals.
4. First Conclusive Evidence Linking Oral Bacteria To Premature Babies
5. Study Provides Evidence That Obesity Leads To A More Aggressive Ovarian Cancer
6. No Clear Evidence for Ultra-Low Cholesterol Targets?
7. Lack of Evidence on Treatment for Narrowed Kidney Arteries
8. Some Evidence Shows Chinese Herbal Medicine Helps Angina Patients
9. Strong Evidence Suggests Incidence Of Mating Of Ancestors With Neanderthals
10. Dermatologists Provide Unique Evidence of Possible Cause of Rare Skin Condition
11. Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine?
Post Your Comments:
(Date:7/25/2008)... New program delivers immediate co...[24-hour telephone access to language interpreters...g multilingual solutions. , ...LLE® http://www.lle-inc.com/index.html [(Lan...ider of interpretation, translation, and language ...
(Date:7/25/2008)... The Drug Information Association ...ill host the Critical Path Initiative (CPI) on the...16; Bethesda, MD) and the Critical Path Transporte... Horsham, PA (PRWEB) July 25...mation Association (DIA)] and the Food and Drug Ad...
(Date:7/24/2008)...TON-SALEM, N.C. Researchers at Wake Forest Unive...-standing clinical belief that the hepatitis C vir...restore itself after HIV patients are treated with..., Hepatitis C (HCV) infection is more serious in...e, according to the Centers for Disease Control. I...
(Date:7/24/2008)...UTH, Minn., July 24 /PRNewswire-FirstCall/ -- ev3 ... to report its 2008 second quarter and,year-to-dat...second quarter,and year-to-date financial results ...ding hours., The company will host a conference c...m. Eastern Time) on Tuesday, July 29, 2008. ev3,ma...
Breaking Medicine News(10 mins):Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2
... manufacturing computer chips. Now, the mega giant...thcare companies’ towards providing quality health...n others have joined hands to enable high-end heal...ntinua Health Alliance, led by Intel will seek to ...
...mputed tomography (CT), magnetic resonance imaging...he newly developed multi-modal contrast agent – Re...na-Champaign says. Use of these new agents may, i...sis and treatment of cancer, according to Kenneth ...
...he class X examination - a feat no girl of her vil...e, some 150 km from the state capital of Bhubanesw...mers. It does not have a school. Jharana Sahu use...ery day to study at a high school in nearby Kalupu...
... interact physically in a biochemical partnership ...ssels. // The study was conducted by researchers ...ne and Queen's University, Ontario, Canada and rep...dicine. The COX enzymes are well-known for their ...
Other Medicine News:Health News:New Multi-Modal Contrast Agents, A Boon For Medical Imaging 2Health News:New Multi-Modal Contrast Agents, A Boon For Medical Imaging 3Health News:New Multi-Modal Contrast Agents, A Boon For Medical Imaging 4Health News:New Role of COX Enzymes Discovered 2
(Date:7/22/2008)...s Including Lantus(R) and Apidra(R) Resulted in Si... 2 Diabetes, Whatever the Algorithm ...22 /- Results from the "Adjust to,Tar...orithm to Carbohydrate,Counting for Adjustment of ...in the American Diabetes Association,s (ADA) medic...
(Date:7/22/2008)... treatment with chemotherapy and pegylated enzyme ...ed to chemotherapy alone - - Pegy... /- Halozyme Therapeutics,... developing and,commercializing products targeting...sentation of positive pre-clinical animal efficacy...
(Date:7/22/2008)...IPOLIS, France, July 22 /- ...t has successfully completed the,enrollment of 417...rtension,in two clinical pharmacology studies in t...d timelines. These trials are designed to assess t...rison to ibuprofen and,naproxen, using the Ambulat...
(Date:7/21/2008)...ing to focus on use of Zevalin as consolidation th...reated patients with follicular ...re-FirstCall/ -- Cell Therapeutics, Inc.,(CTI) (Na...ny has scheduled,a meeting with the U.S. Food and ...the possibility of filing a supplemental Biologics...
Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4American Chemical Societys Weekly Presspac Sept 5 2007 853 1American Chemical Societys Weekly Presspac Sept 5 2007 853 2American Chemical Societys Weekly Presspac Sept 5 2007 853 3American Chemical Societys Weekly Presspac Sept 5 2007 853 4American Chemical Societys Weekly Presspac Sept 5 2007 853 5American Chemical Societys Weekly Presspac Sept 5 2007 853 6American Chemical Societys Weekly Presspac Sept 5 2007 853 7American Chemical Societys Weekly Presspac Sept 5 2007 853 8American Chemical Societys Weekly Presspac Sept 5 2007 853 9Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference 848 1Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference 848 2Biomoda Inc and Quintiles Announce Agreement for Regulatory Consulting 843 1Biomoda Inc and Quintiles Announce Agreement for Regulatory Consulting 843 2Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist 450 1Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist 450 2
...Closure of Multi-Center Trial in 4 Weeks Reinforce...s in Myeloma-, NORTH HOLLYWOOD, Calif., May 15, 20...ation (IMF) - supporting research and,providing ed...,families, researchers and physicians - today sai...enter myeloma trial using,REVLIMID(R) has demonstr...
... Poster Presented at Society for Investigative Der.../ -- AGI Dermatics,recently announced new comparat...cells have the ability to recognize, transport and...nst oxidative,damage, and importantly, that (EGT) ...than idebenone, scavenging reactive oxygen,species...
Other Medicine Technology:The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 2The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 3AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage 2
... into the body more easily than any comparable sco...ching the lower pole calyces. Its smooth, lubricio...on of both scope and instruments. And its patented...us tip, and active secondary deflection deliver co...
...Ureteroscope permits direct visualization and acce... little or no dilation.,A tight bend radius and ...renal access, including the lower pole calyces. Du...reter and the renal pelvis. The 6.75 beveled tip f...
Smooth, contoured standard obturator provides less traumatic insertion through the urethra and into the bladder.
Electrohydraulic Lithotripsy Probe for AEH-4
Medicine Products: